Full Papers
doi.org/10.1002/cctc.202001207
ChemCatChem
mixture was cooled to room temperature to reform a biphasic
mixture. The two layers were separated, and the heptane phase
was washed with DMF (2×25 mL), water (2×25 mL), and brine (1×
2 mmol) was then added into the reaction mixture. The reaction
was stirred at room temperature and aliquots (50 μL) of the
reaction mixture were removed at different time intervals. Each
aliquot was diluted with 1 mL of CH Cl and washed with 1 mL of
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
25 mL). The heptane layer was then dried with MgSO , and the
4
2
2
solvent was removed under reduced pressure using a rotary
evaporator. The product viscous oil was purified by column
aqueous ammonium chloride (NH Cl). The mixture was separated
4
by centrifugation, the two phases were separated, and the CH Cl2
2
chromatography (Brockmann aluminum oxide) to afford 19.2 g of 4
phase was concentrated at reduced pressure using a rotary
1
1
(
(
96% yield). H NMR (CDCl ) δ: 1.00–1.41 (m, 308 H), 2.18 (1H), 2.31
evaporator. The residue dissolved in CDCl and analyzed by H NMR
3
3
13
dd, 1 H), 2.48 (dd, 1 H), 2.53 (m, 2 H); C NMR (CDCl ) δ: 11.8, 14.0,
spectroscopy.
3
21.3, 22.7, 23.2, multiple peaks between 29.0 and 38.1, 47.3, 51.7,
51.9, multiple peaks between 58.4 and 59.5.
Benzaldehyde Allylation and Recycling of Catalyst 5. A scintilla-
tion vial containing a solution of benzaldehyde (0.1 mL, 1 mmol),
DIPEA (0.5 mL), catalyst 5 (0.25 g, 0.0625 mmol) and PAO432 (2 mL)
was prepared. Allyltrichlorosilane (0.29 mL, 2 mmol) was added into
the reaction mixture via a syringe. After 24 h stirring, the reaction
was quenched by adding 5 mL of MeCN. The reaction mixture was
then transferred into a centrifuge tube the phases separated with a
15 min centrifugation. The bottom layer (MeCN phase) separated
and the conversion was analyzed as described above. The PAO
phase was washed with 5 mL of NaOH (4N) and returned to a
scintillation vial for the next cycle. To isolate the product, the MeCN
phase from the five cycles was combined, the solvent was removed
at reduced pressure and the crude 1-phenylbut-3-en-1-ol was
purified by a column chromatography. The product was all
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
2
3
3
3
3
3
3
3
3
3
3
4
4
4
4
4
4
4
4
4
4
5
5
5
5
5
5
5
5
PIB-HMPA 5. Propylamine-terminated PIB oligomer 4 (9.93 g,
9
.9 mmol) was dissolved in 50 mL of anhydrous THF and allowed to
n
react with. 5 mL of BuLi (2.5 M) which was added dropwise. The
reaction solution was allowed to stir for 2 h at room temperature.
Then N,N,N’,N’-tetramethylphosphorodiamidic chloride (2 mL,
14 mmol) was added and the reaction mixture was stirred for 6 h at
room temperature. The solvent was then removed under reduced
pressure using a rotatory evaporator until ca. 10 mL of reaction
residue remained. This viscous residue was then added to a 40-fold
excess volume of cold methanol. The supernatant MeOH was
removed by decantation. The insoluble oil that remained was re-
dissolved in 10 mL of THF. A second solvent trituration using a 40-
fold excess volume of cold methanol to afford the desired product.
The MeOH was again removed and the viscous residue was
1
13
characterized by H, C NMR and IR spectroscopy.
1-Phenylbut-3-en-1-ol: The product was isolated by flash chroma-
collected and dried under vacuum overnight to afford 7.89 g of 5
1
tography (CH
of product/cycle (81%)). H NMR (500 MHz, CDCl
m, 2H), 4.74 (m, 1H), 5.17 (m, 2H), 5.82 (m, 1H), 7.27–7.37 (m 5H).
Cl /hexanes=8/1, v/v) as colorless liquid (0.6 g, 0.12 g
2 2
1
as a dark orange oil. H NMR (CDCl , δ): 2.62–2.87 (m, 16H), 1.0–1.41
3
13
, δ): 2.19 (1H), 2.53
3
(m, 272H). C NMR (CDCl
, δ): 11.6, 14.1, multiple peaks between
3
(
2
4
2
1
0.6 and 32.5, 34.6, 35.9, multiple peaks between 36.0 and 38.2,
13
31
C NMR (125 MHz, CDCl
3
, δ): 43.7, 73.3, 118.3, 125.7, 127.5, 128.3,
5.8, multiple peaks between 51.1 and 59.5. P NMR (CDCl , δ):
3
À 1
À 1
À 1
134.4, 143.8. IR (neat) data: 3386, 3066, 3031, 2909, 1641 cm .
5.3 ppm. GPC data: M =1,700 gmol , M =2,800 gmol , Đ=
n
w
.65. The exact amount of the phosphoramide per gram was
Lewis Base-Catalyzed Allylation of Other Aromatic aldehydes. These
reactions were all carried out on a 0.1 mmol scale following the
procedure used for benzaldehyde. 5 used here was the other batch
from the experiment of benzaldehyde allylation and recycling of
catalyst 5. The HMPA amount was calculated accordingly (0.25 g,
1
determined by H NMR spectroscopy using dichloroethane as an
internal standard and varied from 0.4 to 0.25 mmol/g.
Phase Selectivity Solubility of Catalyst 5 in PAO432 or heptane
versus MeOH. 0.25 g of 5 was dissolved in 2 mL of PAO432. Then the
PAO432 phase was vigorously mixed with 2 mL of 0.03 M of H PO in
1
mmol). Products from the combined MeCN phases from 5 cycles
3
4
were further purified by a column chromatography and character-
ized by H, C NMR and IR spectroscopy.
MeOH for 48 h. The biphasic mixture was transferred into a
centrifuge tube and underwent a 15-min centrifugation. 0.4 mL of
1
13
1
the MeOH and PAO phase was taken individually and directly
432
1-(p-Tolyl)but-3-en-1-ol: H NMR (500 MHz, CDCl , δ): The product
3
31
analyzed by P NMR spectroscopy. The phase selectivity of 5 in
heptane with MeOH was also studied and analyzed via the same
procedure. The catalyst 5 showed high phase selectivity solubility
in PAO432 (>99.9%) and the MeOH phase showed no detectable
was isolated by a flash chromatography (EA/hexanes=1/4, v/v) as
colorless liquid (0.57 g, 0.11 g of product/cycle (70%)). 1.97 (d, J=
3
Hz, 1H), 2.35, (br, s, 3H), 2.51 (m, 2H), 4.71 (m, 1H), 5.14 (m, 2H),
13
5.81 (m, 1H), 7.16 (d, J=8 Hz, 2H), 7.25 (d, J=8 Hz, 2H).
C NMR
signal from 5. The internal standard H PO also had no leaching to
3 4
(125 MHz, CDCl , δ): 21.1, 43.7, 73.2, 118.2, 125.7, 129.1, 134.6,
3
the PAO432. However, a phase selectivity solubility of 5 in heptane
versus MeOH showed ca. 4.8% 5 leached from heptane to the
MeOH phase.
137.2, 140.9. IR (neat) data: 3391, 3076, 2935, 2929, 2924, 1640,
À 1
1
514 cm .
1-(4-Methoxyphenyl)but-3-en-1-ol: The product was isolated by a
Phase Selectivity Solubility of Catalyst 5 and 1-phenylbut-3-en-1-
ol in PAO432 versus MeCN. 0.25 g of 5 was dissolved in in 2 mL of
PAO432 and vigorously mixed with 2 mL of 0.5 M of 1-phenylbut-3-
en-1-ol in MeCN for 1 min. The biphasic mixture was transferred
into a centrifuge tube and underwent a 15-min centrifugation. An
aliquot (100 μL) was taken from both the MeCN and PAO phase
flash chromatography (EA/hexanes=1/4, v/v) as yellow liquid
1
(0.6 g, 0.12 g of product/cycle (67%)). H NMR (500 MHz, CDCl , δ):
3
1.96 (s, 1H), 2.51 (m, 2H), 3.81 (s, 3H), 4.69 (m, 1H), 5.14 (m, 2H), 5.79
1
3
(
m, 1H), 6.88 (d, J=8.5 Hz), 7.28 (d, J=8.5 Hz). C NMR (125 MHz,
CDCl , δ): 43.7, 55.2, 72.9, 113.7, 118.1, 127.0, 134.6, 136.0, 158.9.IR
3
À 1
4
32
(neat) data: 3428, 3076, 2972, 2932, 1611, 1512 cm .
1
and analyzed by H NMR spectroscopy in CDCl
using 0.2 M of
3
1
-(4-fluorophenyl)but-3-en-1-ol: The product was isolated by a flash
dichloroethane as an internal standard. The amount of 5 that
leached into the MeCN phase was calculated to be <0.1% and the
amount of leaching of 1-phenylbut-3-en-1-ol into the PAO phase
chromatography (EA/hexanes=1/5, v/v) as yellow liquid (0.63 g,
1
0.13 g of product/cycle (75%)). H NMR (500 MHz, CDCl , δ): 2.04 (s,
3
4
32
1
1H), 2.48 (m, 2H), 4.72 (m, 1H), 5.16 (m, 1H), 5.79 (m, 1H), 7.03 (m,
was calculated to be 1.6% based on H NMR spectroscopy.
13
2H), 7.32 (m, 2H). C NMR (125 MHz, CDCl , δ): 43.9, 72.6, 115.1,
3
Typical Procedure for Kinetic Studies of Allylation of Benzalde-
hyde. For the kinetic studies, benzaldehyde (0.1 mL, 1 mmol), DIPEA
1
3
15.2, 118.6, 127.4, 127.5, 134.1, 139.5, 161.1, 163.1. IR (neat) data:
393, 3077, 2976, 2934, 1641, 1603, 1509 cm .
À 1
(
0.5 mL), and catalyst 5 (0.25 g, 0.1 mmol) were dissolved in 2 mL of
Reduction of Various α,β-Unsaturated Carbonyl Compounds by 5
in PAO432 and Catalyst Recycling. A 10-mL round-bottomed flask
CH Cl . HMPA or 5 was then added at a concentration of 10 mol%
2
2
(0.1 mmol of an HMPA equivalent). Allyltrichlorosilane (0.29 mL,
ChemCatChem 2020, 12, 1–10
7
© 2020 Wiley-VCH GmbH
��
These are not the final page numbers!